For most of neuroscience's history, the brain's story has been told almost entirely through its neurons — the cells that fire, signal, and seem to think. Yet half the brain's cells are glia, and a new study from the Salk Institute suggests these long-overlooked cells are not mere custodians but active architects of brain function, organized with regional precision that evolution has preserved across mammalian species. Published in October 2025, the research quietly reframes a century of assumptions, asking whether we have been studying the brain's mind while neglecting its body.
Glia cells rival neurons in shaping brain function, study reveals
Cobertura Relacionada
NASA's Curiosity rover has photographed a striking honeycomb-like polygonal pattern on Mars' surface in Gale Crater, alo…
ScienceDaily · Jul 16 Quantum breakthrough links light and magnetism in atomically thin materialsResearchers demonstrate how light and magnetism interact directly in atomically thin materials, enabling optical control…
Mirage News · Jul 16 Nearly a quarter of UK smokers now buy from illicit sources, study findsA study of nearly 10,000 UK smokers found 23.1% purchased tobacco from illicit sources in 2025, nearly double the 12.2% …
The Times of India · Jul 16 NASA warns US coastal cities face up to 18 inches of sea level rise by 2050NASA satellite data indicates US coastal cities could experience sea level rises of up to 18 inches by 2050, with Gulf C…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
This is a neuroscience research article with no geopolitical implications; it concerns brain cell biology, not international relations or global affairs.
Lente Económico
Neuroscience research reveals glial cells rival neurons in brain function, potentially redirecting billions in biomedical R&D toward understudied cell types and creating new therapeutic markets.
Long-term potential for improved treatments of neurological diseases (Alzheimer's, Parkinson's, multiple sclerosis, brain injuries) as understanding of glial dysfunction expands, potentially reducing healthcare costs and improving quality of life for millions with brain disorders.
Likely increase in NIH and NSF funding allocation toward glial cell research; potential shift in drug development priorities by FDA; possible new diagnostic criteria for neurological conditions; increased investment in neuroscience infrastructure and training programs focused on non-neuronal brain cells.